Skip to main content
Top

International Journal of Hematology

Issue 5/2022

Including PIH articles on Clinical aspects and treatment options in myeloproliferative neoplasms

Content (16 Articles)

Lymphoma Images in Hematology

Clostridium septicum myonecrosis following chemotherapy

Omali Pitiyarachchi, Nicholas Viiala

COVID-19 Vaccination Rapid Communication

Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation

Takafumi Tsushima, Toshiki Terao, Kentaro Narita, Ami Fukumoto, Daisuke Ikeda, Yuya Kamura, Ayumi Kuzume, Rikako Tabata, Daisuke Miura, Masami Takeuchi, Kosei Matsue

Anemia Progress in Hematology

Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives

Giuseppe G. Loscocco, Alessandro M. Vannucchi

Ruxolitinib Progress in Hematology

Novel treatments for myelofibrosis: beyond JAK inhibitors

Douglas Tremblay, Ruben Mesa

Retrovirus Original Article

UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8

Tomofusa Fukuyama, Toshio Kitamura, Tomoko Kozu

A phase II randomized study evaluating azacitidine versus conventional care regimens in newly diagnosed elderly Japanese patients with unfavorable acute myeloid leukemia

Hiroatsu Iida, Kazunori Imada, Yasunori Ueda, Kohmei Kubo, Akira Yokota, Yoshikazu Ito, Toru Kiguchi, Tomoko Hata, Yuichiro Nawa, Takayuki Ikezoe, Toshiki Uchida, Yasuyoshi Morita, Ichiro Kawashima, Masahiro Chiba, Kensaku Morimoto, Shihomi Hirooka, Yasushi Miyazaki, Ryuzo Ohno, Tomoki Naoe, Kensuke Usuki, Kiyoshi Ando, Takahiro Yamauchi, Junya Kuroda, Takayuki Ishikawa, Hiromi Iwasaki, Takahiro Suzuki, Kenichi Kitamura, Hitoji Uchiyama, Satoshi Ichikawa, Kenji Imajo, Hitoshi Hanamoto, Shuichi Miyawaki, Noriko Usui, Norio Asou, Akihiro Hirakawa, Kazutaka Kuriyama, Masakazu Muta, Masafumi Taniwaki, Yukari Takahashi, Atsushi Dohi, Yoko Nakanishi, Ryuhei Nakaoka

NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan

Wen-Li Hwang, Tsung-Chih Chen, Hsuan-Yu Lin, Ming-Chih Chang, Pei-Ching Hsiao, Li-Yuan Bai, Ching-Yuan Kuo, Yeu-Chin Chen, Ta-Chih Liu, Jyh-Pyng Gau, Po-Nan Wang, Wei-Shou Hwang, Ming-Chung Kuo, Chun-Yu Liu, Yi-Chang Liu, Ming-Chun Ma, Nai-Wen Su, Chuan-Cheng Wang, Yi-Ying Wu, Ming Yao, Su-Peng Yeh, Hao-Wei Cheng, Yee-Ming Lee, Fan-Chen Ku, Jih-Luh Tang

Filgrastim Original Article

A retrospective single-center analysis of G-CSF-mobilized donor lymphocyte infusion in hematologic malignancies after unmanipulated allogenic PBSCT

Ning Lu, Ji Lin, Li-Li Wang, Yu-Yan Li, Li-Jun Wang, Chun-Ji Gao, Dai-Hong Liu, Xiao-Ning Gao

Lymphoma Original Article

Antibody response to COVID-19 vaccination in patients with lymphoma

Kentaro Narita, So Nakaji, Rikako Tabata, Toshiki Terao, Ayumi Kuzume, Takafumi Tsushima, Daisuke Ikeda, Ami Fukumoto, Daisuke Miura, Masami Takeuchi, Masahiro Doi, Yuka Umezawa, Yoshihito Otsuka, Hiroyuki Takamatsu, Kosei Matsue

Multiple Myeloma Original Article

Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma

Toshiki Terao, Takeshi Yamashita, Ami Fukumoto, Yuya Kamura, Daisuke Ikeda, Ayumi Kuzume, Rikako Tabata, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Masahiro Doi, Yuka Umezawa, Yoshihito Otsuka, Hiroyuki Takamatsu, Kosei Matsue

Leukemia Case Report

Emergence of clone with PHF6 nonsense mutation in chronic myelomonocytic leukemia at relapse after allogeneic HCT

Yu Akahoshi, Hideki Nakasone, Machiko Kusuda, Kazuaki Kameda, Yuhei Nakamura, Masakatsu Kawamura, Junko Takeshita, Shunto Kawamura, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Shimpei Matsumi, Ayumi Gomyo, Aki Tanihara, Masaharu Tamaki, Shun-ichi Kimura, Shinichi Kako, Yoshinobu Kanda

Relationship between donor-specific HPA-15 antibodies and poor graft function in HPA-15 mismatched cord blood transplantation

Masato Yasumi, Takafumi Yokota, Takaya Endo, Shinsuke Kusakabe, Yangsook Koh, Hiroe Sakamoto, Hiroko Inoue, Takao Sudo, Naoki Hosen, Takahiro Karasuno

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine